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ABSTRACT. Optical coherence tomography (OCT) is an imaging technique affording non-
invasive optical biopsies. Like for other imaging techniques, the use of dedicated contrast 
agents helps better discerning biological features of interest during the clinical practice. 
Although bright OCT contrast agents have been developed, no dark counterpart has been 
proposed yet. Herein, we report plasmonic copper sulfide nanoparticles as the first OCT dark 




virtually possess no light scattering capabilities at the OCT working wavelength (approx. 1300 
nm); thus, they exclusively absorb the probing light, which in turn results in dark contrast. The 
small size of the nanoparticles and the absence of apparent cytotoxicity support the amenability 
of this system to biomedical applications. Importantly, in the pursuit of systems apt to yield 
OCT dark contrast, we prepared a library of copper sulfide nanoparticles featuring plasmonic 
resonances spanning the three optical transparency windows, thus highlighting the versatility 




Sometimes, the most valuable gifts are those we cannot see with our eyes. As philosophical as 
it might sound, this sentence well embodies the spirit of the latest research in the field of optical 
biomedical techniques. With the advancement of our knowledge around the interaction between 
light and biological tissues, we quickly realized the advantage of moving further down the 
electromagnetic spectrum and choosing near-infrared (NIR) light over visible.[1-3] The concept 
of optical transparency windows is now well consolidated and has spurred the development of 
approaches that make use of specific NIR light to penetrate and probe deeper, with more 
precision within human tissues. Particularly the second transparency window, also referred to 
as NIR-II (1000-1400 nm), represents an excellent porthole to peek beneath the skin surface: in 
fact, it grants an ideal trade-off between reduced scattering, absorption and autofluorescence 
from tissue components.[2, 4] Embracing these notions, we herein report the first example of 
dark contrast agent for optical coherence tomography (OCT) working in the NIR-II, leveraging 
on the plasmonic resonance of noble-metal-free CuS NPs. 
OCT is a diagnostic technique that takes advantage of the partial transparency of tissues in the 
optical transparency windows. It affords optical biopsies of tissues in a fast, non-invasive 
way.[5-7] These traits make OCT a powerful diagnostic tool, for instance, in ophthalmology,[8, 9] 




relies on recording light back-scattered from tissue components at different depths, whose 
intensity and/or echo time delay are then elaborated to build 2D (B-scans) or 3D images of the 
investigated area. Although bright contrast agents (i.e., highly-scattering species) are often 
sought after in order to increase the signal of specific sites of interest,[15, 16] the already bright 
OCT signals provided by some highly-scattering tissues and tissue interfaces (such as blood-
artery wall interface) makes this contrast method impractical in some circumstances. For 
instance, dark contrast agents could ensure early detection of atheromatous plaques, which 
nowadays can only be imaged via angiography or computed tomography at a relatively 
advanced stage, when calcification is taking place.[17] Thus, OCT imaging could greatly benefit 
from dark contrast agents (i.e., strongly absorbing species), which have yet to be reported to the 
best of our knowledge. 
A viable avenue to improve contrast in an OCT scan is to use NPs featuring localized surface 
plasmon resonance (LSPR) at the probing OCT wavelength.[18, 19] Among plasmonic NPs, gold-
based nanostructures are generally the species of choice, because of the possibility to finely 
tailor their LSPR band over a broad visible-to-NIR range.[20, 21] However, they are costly and 
architectures above or close to 100 nm have to be prepared to push the LSPR deep into the NIR 
region, as in the case of high-aspect-ratio gold nanorods (GNRs)[22], gold nanoprisms[15] or gold 
nanoshells (GNSs).[19] Particles in that size range might undergo a troublesome body clearance–
an unwanted side-effect seeking optical imaging. GNSs in particular have been used as bright 
contrast agents in OCT, owing to the marked scattering component of their light extinction.[18, 
19, 23-25] In actuality, it is challenging to prepare small gold nanostructures featuring LSPR with 
a strong absorption in NIR-II and in the third transparency window (NIR-III; 1500-1870 nm). 
Copper sulfide in offers the opportunity to complement the toolbox of plasmonic NPs for 
biomedical applications, easily reaching where gold-based systems have to stretch. Copper 
sulfide NPs feature a LSPR conveniently centered in the NIR, even when their size is below 10 




efficiency.[28] Because the LSPR arises from the motion of vacancies delocalized in the 
material’s valence band, the spectral position of this feature can be controlled by various means, 
such as NP size, morphology and stoichiometry (CuxS, where x varies from 1 to 2).[29-31]  
Following this reasoning, capitalizing on the negligible light scattering of small CuS plasmonic 
NPs, we report on the first example of OCT dark contrast agents operating in NIR-II. These 
highly-absorbing contrasts agents have properties that are complementary to those of reported 
highly-scattering species (such as most gold nanostructures), opening new scenarios for OCT 
imaging that were not conceivable with bright contrast agents – such as atheromata early 
detection. Importantly, en route to these contrast agents, we prepared a library of copper sulfide 
NPs with variable size, structure and morphology and whose LSPR bands fall in all three optical 
transparency windows, thus showcasing the versatility of these species in the biomedical 
context. 
 
2. Results and discussion 
Identification of the most promising dark contrast agent. 
In the quest for copper sulfide NPs with a plasmonic resonance centered at the working 
wavelength of the OCT instruments used in this study (1300 and 1320 nm), two different 
approaches were pursued: i) thermolysis of copper complexes in high-boiling-point solvents 
followed by transfer to aqueous media and ii) direct synthesis in water. The results of the 
syntheses carried out in water are reported in Figure S1 and discussed in the Supporting 
Information. In fact, the best results in terms of LSPR band spectral position and intensity were 
obtained following the first approach (Figure S2). Copper sulfide NPs were obtained via 
thermolysis in oleylamine (OLAm) of three different complexes: Cu(dedtc)2, Cu(tba)2, and 
Cu(xan) (dedtc – diethyldithiocarbamate; tba – thiobenzoate; xan – ethyl xanthate). Infrared 
absorption spectra of these complexes are reported in Figure S3. The NP growth from Cu(tba)2 




morphologies were observed, which then grew into more homogeneously dispersed hexagonal 
plates. Above 200 °C, larger particles were formed, leading to size distribution broadening. The 
sample synthesized from Cu(dedtc)2 featured instead larger plates of dissimilar sizes and 
morphologies already from the first stages of the reaction (Figure S2). This behavior is in line 
with the observation that, unlike Cu(dedtc)2, Cu(tba)2 and Cu(xan) decompose in the presence 
of OLAm already at room temperature yielding copper sulfide NPs (Figure S4). The stronger 
reactivity exhibited by those latter complexes results in faster decomposition kinetics. This 
leads to the production of a larger number of nuclei and the growth of more, smaller particles. 
From this pre-screening of the reaction conditions, we identified copper sulfide NPs obtained 
from the thermolysis of Cu(tba)2 at 200 °C (Figure 1) as the most promising candidates for 
advancing our study, owing to a good homogeneous size distribution, small size and NIR-II-
centered LSPR band. The NPs obtained under those conditions were dispersible in common 
organic solvents, such as toluene, chloroform and tetrahydrofuran. OLAm molecules on the 
surface could be easily displaced by thiolated polyethylene glycol (PEG-SH), thus resulting in 
hydrophilic NPs (Figure 1A). The plate-like NPs were 24.4 and 4.0 nm in diameter and 
thickness, respectively (Figure 1B). When they were dispersed in water, they featured a 
hydrodynamic size of approximately 25.2 nm, as obtained from dynamic light scattering (DLS) 
measurements (Figure 1C). This value was well in accordance with the geometrical size 
determined from transmission electron microscopy (TEM) observations and suggested the 
presence of individual, non-aggregated NPs in the dispersion. Importantly, the crystalline 
structure of the synthesized copper sulfide NPs was covellite, whose stoichiometry is CuS 
(Figure 1D). This observation is pivotal in this context since, among the several CuxS materials, 
CuS is the one that supports the most intense LSPR. The reason for this is the larger density of 
empty states in the top of the valence band featured by covellite compared to other 






Figure 1. A) TEM images of CuS NPs synthesized at 200 °C from Cu(tba)2, capped with OLAm 
(dispersed in chloroform) and PEG-SH (dispersed in water). Scale bars are 100 nm. B) 
Geometrical diameter and thickness of the plate-like CuS NPs as obtained from TEM images. 
C) Results of DLS measurements performed on a phosphate buffer (1x PB) dispersion of PEG-
SH-capped CuS NPs. D) X-ray diffraction (XRD) pattern of the CuS NPs compared to reference 
covellite pattern (PDF card # 01-078-2121).  
 
Indeed, the synthesized CuS NPs possessed a strong LSPR band, which peaked around 
1400 nm–well overlapping with the OCT wavelength used in this study (approx. 1300 nm) 
(Figure 2A). The contribution at shorter wavelengths (below 500 nm) arises from photon  
absorption phenomena promoting electrons from the valence to the conduction band of CuS 
NPs. As expected, the LSPR band experienced a slight bathochromic shift (1396 to 1356 nm) 
upon transferring the NPs from toluene to water. This is a result of the different refractive index 
of the solvents (𝑛𝑡𝑜𝑙𝑢𝑒𝑛𝑒 = 1.495 , 𝑛𝐻2𝑂 = 1.33 ) and the LSPR sensitivity towards this 
parameter.[26] The calculated extinction profile in water, shown in Figure 2B, is the result of 
full-wave electrodynamic simulation performed with COMSOL, a commercial finite element 




plate (see inset in Figure 2B) immersed in a homogeneous dielectric matrix with a refractive 
index accounting for the presence of the capping agent (i.e., PEG-SH). The extinction cross 
section reported in Figure 2B has been averaged over the light’s incidence and polarization, to 
mimic the experimental conditions of a colloidal solution. Results for the longitudinal and 
transversal plasmonic resonances of the plate can be found in the Supporting Information 
(Figure S5), alongside all the relevant parameters used in the theoretical model. 
These theoretical results highlight a fundamental point: because of the small size of CuS NPs 
and the relatively large damping rate of the CuS, the extinction coefficient is dominated by the 
 
Figure 2. A) Extinction spectra of CuS NPs in toluene (dark green) and in water (light green), 
respectively before and after exchanging surface OLAm molecules for PEG-SH. Dashed 
segments in the spectrum of the aqueous dispersion were manually drawn in correspondence of 
strong water absorption regions. B) Simulated extinction cross section (ext) of CuS NPs in 
water, along with the ratio of absorption (abs) over the total extinction (ext) that includes both 
absorption and scattering (scat) components. C) Heating-cooling curves obtained from 
irradiation of water (light blue) and CuS NPs aqueous dispersion (light green) with 1280 nm 
laser. Black lines in the cooling parts of the curves are single exponential fits to the data. D) 
Absorption efficiency at 1280 nm (as experimentally calculated) versus NP largest feature of 
plasmonic NPs investigated as OCT contrast agents (GNSt – gold nanostar). The data shown in 




absorption contribution. The accompanying curves in Figure 2B show that, indeed, at around 
1300 nm approximately 99% of the energy of the excited plasmon will be absorbed rather than 
contribute to scattering. 
Providing additional experimental support for this point, the heat conversion efficiency () of 
the system was evaluated under excitation with a 1280 nm laser diode according to an already 
reported approach (Figure 2C and Figure S6).[18] In fact, considering radiative relaxation 
pathways negligible, the totality of the absorbed light should be converted to heat. Therefore, 
under adequate experimental conditions,  provides a fair estimation of the absorption-vs-
scattering cross section (abs vs scat) of the plasmonic NP under study: the closer to 100% the 
value of this parameter, the more similarly the NPs behave as perfect absorbers. Following the 
guidelines provided by Roper et al.[33], we calculated  to be (93 ± 3)% using the relation: 
Where Qext is heat injected into the NP dispersion and Q0 is the heat dissipated by water. At the 
denominator is the radiated power extinguished solely by the NPs, which is a function of the 
total power (I) of the impinging light and the optical density (OD) of the dispersed NPs at the 
excitation wavelength (i.e., 1280 nm). The heat inputs at the numerators are experimentally 
determined as a function of the time constants (), which are in turn derived from the single 
exponential fit of the cooling part of the temperature profiles (black lines in Figure 2C). 
Additional details for  calculations can be found in the Supporting Information. 
As we highlighted in a previous study,[28] the methods for the experimental determination of  
are usually affected by experimental conditions such as dispersant absorption properties and 
concentration of the dispersed NPs. Thus,  is really a parameter describing macroscopically 








surprise that the non-negligible absorption of water at 1280 nm (Figure 2A) and an optical path 
of finite size (approximately 2.8 mm) led to a value of  slightly smaller than the magnitude 
relating solely to the microscopic properties of the particles (i.e., abs/ext ratio).  
All in all, the values obtained from simulations and experiment together proved that in these 
CuS NPs 𝜎𝑒𝑥𝑡 ≅ 𝜎𝑎𝑏𝑠. At this point it is important to underscore how, among the plasmonic 
NPs investigated so far, these CuS NPs are the one that lend themselves best to be used OCT 
dark contrast agents (Figure 2D). This is because they combine almost exclusive light 
absorption at the selected NIR wavelength and small size, which are invaluable assets in this 
framework, allowing for the best imaging performance and subsequent body clearance. In fact, 
although GNRs might be also effectively yield dark contrast, their high aspect ratio and 
relatively large size are generally regarded as drawbacks in terms of prolonged residence times, 
difficult excretion and cytotoxic effects.[34, 35] Not less importantly, the lack of gold in the 
composition of CuS NPs is another attractive characteristic of the developed system cost-wise. 
 
Cytotoxicity tests. 
Aiming for application in biomedical context, the toxicity of the PEG-SH-capped CuS NPs was 
probed via MTT assay[36] (Figure 3). We conducted two different tests, incubating HeLa cells 
at 4 and 24 h with different concentrations of particles, as already reported in the literature.[37, 
38] For the first set of tests, higher concentrations were chosen (from 0.05 to 1.00 mg/mL), which 
are not expected to persist upon injection of the CuS NPs suspension in the body and its mixing 
with biological fluids therein present. Concentrations falling in a range more closely mimicking 
foreseeable in vivo conditions were selected for long terms assays (from 0.01 to 1.00 μg/mL). 
Both set of assays did not show evidence of significant cytotoxicity on the tested cell line, with 
a maximum decrease of 13% on cell viability at the highest concentration tested (1.00 mg/mL). 






Figure 3. Viability percentage of HeLa cells incubated for 4 and 24 h with dispersions of CuS 
NPs at different concentrations. Data are presented as mean ± SD (n = 4). 
 
Optical coherence tomography imaging. 
To prove the aptness of CuS NPs to act as dark OCT contrast agents, we firstly compared the 
B-scans of Eppendorf tubes filled with dispersions of CuS NPs, GNSs and water (Figure 4). 
We employed a spectral domain (SD) OCT (TelestoTM-II, Thorlabs), with a working 
wavelength centered at 1300 nm. The bright contrast afforded by the GNSs was in line with 
the behavior that we previously observed with these same NPs, and followed from the strong 
scattering of these species at the probing wavelength.[18, 19] The lack of scattering from CuS 
NPs resulted in the total absence of signal inside the tube, similarly to what was observed for 
water. Following this experimental observation, we moved to test the usefulness of dark 
contrast when analyzing highly scattering tissues, such as those high in fat. For this purpose, 
store-bought pork fat was used (Figure 5). In an excised piece of fat, we laterally injected 
approximately 15 μL of a 0.4 mg/mL dispersion of CuS NPs in 1x PB (Figure 5A). The 
injection was executed immediately below the surface (depth < 0.5 mm). This operation was 





Figure 4. OCT B-scans of Eppendorf tubes containing (from top to bottom): dispersion of CuS 
NPs in 1x PB, aqueous dispersion of GNSs, water. 
 
(Figure 5B), and two OCT scans were performed in correspondence of the areas where the 
dispersions were injected (Figures 5C and 5D). We selected two regions with a relatively flat 
surface, in order to ensure that differences in the signal observed below the tissue surface 
were not stemming from topological variability. It is clear how in correspondence of the area 
where CuS NPs were injected, the OCT signal sizably decreased compared to the untreated 
zone (Figure 5C). To assess semi-quantitatively the effect of the presence of the dark contrast 
agents, we integrated the OCT signal over a rectangular region of interest (ROI) beneath the 
tissue surface. The results show that the signal decreased approximately 3.6 times in the zone 
where CuS NPs were injected. The OCT B-scan obtained on the area injected with GNSs was 
similarly analyzed. Already at a visual inspection, it resulted challenging to identify the region 
where the GNSs were located (Figure 5D). The integration procedure conducted also for CuS 
NPs did not allow to discern the signal coming from the GNSs either. Further tests were 
conducted using a time domain (TD) OCT system for intravascular imaging (DragonflyTM 




The catheter was sandwiched between a pristine excised piece of pork fat (top) and one 
injected with 15 μL of a 0.4 mg/mL CuS NPs suspension (bottom). OCT images were 
obtained in correspondence of the zones indicated with 1 and 2 in Figure 5E, those being 
areas of pristine tissue and bearing CuS NPs, respectively. Similarly to what was observed in 
the SD-OCT images, Figure 5G shows the appearance of a darker area in correspondence of 
the injected CuS NPs, hence supporting the potential of these particles to be used as OCT dark 
 
Figure 5. Results of the OCT tests conducted using a SD-OCT instrument (A-D) and an OCT 
instrument for intravascular imaging (E-G). A) Sketch of the approach employed to test the 
dark contrast abilities of CuS NPs in pork fat, along with a visualization of the mechanism 
giving rise to dark contrast. B) Picture of the specimen of the imaged pork fat post injection of 
CuS NPs and GNSs suspensions. C and D) OCT B-scans obtained in correspondence of the 
areas where the two types of contrast agents were respectively injected, along with the OCT 
signal intensity derived from the signal integration on the ROIs indicated in the scans. E) 
Breakdown of the setup employed for the OCT test using a catheter. The red light observed in 
the catheter is an idle signal used to indicate where the 1320 nm probing light and the rotating 
mirror are located. The two rectangles labelled 1 (pristine tissue) and 2 (injected CuS NPs) in 
the middle picture indicate respectively the areas where the OCT images shown in G were 
recorded. F) Sketch of section indicated in the bottom picture in E, showing how dark contrast 
is generated. G) OCT images obtained from the two areas highlighted in E. All scale bars (in 




contrast agents. Importantly, the use of dark contrast agents in intracoronary (IC)-OCT opens 
the avenue towards molecular imaging of atheromatous plaques, otherwise hardly observable 
due to their intrinsic bright contrast in OCT scans. 
A bigger picture. 
The results of this study are expected to spur the research in the field of OCT dark contrast 
agents, complementing the toolbox of this powerful, non-invasive diagnostic approach. In fact, 
we are not suggesting that the use of dark contrast agents would be a better way to visualize 
features of interest in biological tissues broadly speaking. It is known, for instance, that breast 
cancer cells might appear already darker than the tissues around them in OCT images.[39] Hence, 
dark contrast would not be beneficial in this situation. Also, many OCT-based techniques make 
use of the backscattered light, extracting information not only from its intensity but also from, 
e.g., its phase and polarization. In those cases, already proposed gold-based plasmonic particles, 
such as high-aspect ratio GNRs and GNSs, are the contrast agents of choice, since they possess 
unrivalled light scattering capabilities in the optical transparency windows (NIR-I and NIR-II 
above all). Nonetheless, as mentioned above, imaging of atheromata is one of the foreseeable 
applications where CuS NPs could provide undeniable advantage over bright contrast agents. 
The next steps in this direction would be to modify the surface of CuS NPs with targeting 
moieties promoting selective accumulation at lipid-rich sites on the artery wall. Assessment of 
the state of atheromateous plaques at an early stage would therefore become possible, with 
tremendous benefits in terms of prevention of coronary diseases. More in general, highly 
scattering tissues, which naturally appear bright in OCT images, could be expected to be better 
investigates using highly absorbing (rather than highly scattering) contrast agents.  
Going one step further, the data herein reported has an even broader appeal. En route to CuS 
NPs suitable to act as dark contrast agents, we uncovered the full arsenal of potential of NIR-
absorbing plasmonic copper sulfide NPs. This is appreciable from the reported extinction 




possibility to cover an incredibly broad wavelength range in the NIR, which encompass all three 
transparency windows, i.e., NIR-I (750-950 nm), NIR-II (1000-1400 nm) and NIR-III (1500-
1870 nm). Size, morphology and crystal structure/stoichiometry are the parameters governing 
the plasmonic properties of these systems. Careful selection of reaction conditions and 
precursors grants the control over those parameters, thus making it possible to tailor the 
properties of the plasmonic copper sulfide NPs to the needs of the application sought after. For 
instance, the high heat conversion efficiency measured for the investigated CuS NPs makes 
them ideal also in the context of photothermal therapy in NIR-II. Small covellite NPs (light 
green) where obtained directly in water using citrate molecules as capping agents, using a 
modified reported approach.[40] They showed a LSPR band mainly centered in NIR-I, while 
hydrophilic copper sulfide NPs obtained in the presence of acetylacetonate featured an 
absorption falling prominently within NIR-II (dark brown). The attribution to yarrowite crystal 
structure was supported by elemental analysis performed on this sample, which returned a Cu/S 
ratio of 1.15 ± 0.03, compatible with that of yarrowite (1.125). Stunningly, absorption in NIR-
III could be easily achieved with copper sulfide NPs derived through the already reported 
thermolysis of copper thiocyanate (CuSCN) in OLAm,[41] and subsequent transfer to water 
following the same procedure adopted for CuS NPs (light brown). Given the relatively small 
size of these particles, the LSPR band of this sample is also expected to have an almost purely 
absorptive behavior. Because of these properties, these particles may conceivably perform as 
OCT dark contrast agents for instruments working at 1700 nm.[42] Clearly, other imaging 
techniques relying on light as a probing mean such as photoacoustic imaging,[43] could greatly 
benefit from the use of this gamut of small, NIR-absorbing NPs. Moreover, the incorporation 
of the 64Cu reactive isotope in copper sulfide NPs enables their use in positron-emission 
tomography, thus opening the door to the preparation of multifunctional biological labels for 






Figure 6. TEM images (A), extinction spectra (B), geometrical and hydrodynamic size (C), and 
X-ray diffraction patterns (D) of the copper sulfide NPs synthesized in the quest for OCT dark 
contrast agents. Scale bars in A are 100 and 20 nm for the two top and the two bottom TEM 
images. In C, the geometrical size reported is the largest NP’s feature (i.e., for plate-like 
particles, the thickness is not reported). The reference patterns in D are taken from PDF # 01-
078-2121 (covellite), # 00-036-0379 (yarrowite), # 00-023-0958 (roxbyite). In E, some of the 
possible applications of copper sulfide NPs in the biomedical context are presented. 
 
3. Conclusion 
We herein reported the first example of optical coherence tomography (OCT) dark contrast 
agent, in the form of plasmonic copper sulfide nanoparticles working in the second optical 
transparency window. The synthesized nanoparticles featured the optimal characteristics for 
OCT dark contrast agents: small size, no observed cytotoxicity and negligible light scattering 
at the working wavelengths of the employed OCT instruments–which worked respectively in 




developed a full library of copper sulfide nanoparticles with small size and plasmonic resonance 
bands covering all three optical transparency windows. Overall, the results we herein reported 
not only show the possibility of achieving dark contrast in OCT, thus expectedly encouraging 
the research towards the improvement and development of novel such contrast agents. Even 
more importantly, from a broader perspective, we point out the remarkable potential of these 




Sodium diethyldithiocarbamate trihydrate (Na(dedtc)·3H2O, 98%, Alfa Aesar), thiobenzoic 
acid (Htba, 90%, Acros Organics), potassium ethyl xanthate (K(xan), 97+%, Acros Organics), 
potassium carbonate (K2CO3, Fisher), copper chloride dihydrate (CuCl2·2H2O, 99%, Alfa 
Aesar), copper thiocyanate (CuSCN, 96%, Alfa Aesar), mercaptopropionic acid (MPA, 99%, 
Alfa Aesar), trisodium citrate (Na3(cit), 98%, Acros Organics), mercapto hexadecanoic acid 
(MHDA, 90%, Aldrich), acetyl acetone (Hacac, 99.5%, Riedel-de-Haën), 
ethyldiaminotetracetic acid (H4EDTA, 99%, Acros Organics), glutathione reduced (GSH, 
98+%, Alfa Aesar), sodium sulfide nonahydrate (Na2S·9H2O, 98%, Alfa Aesar), polyethylene 
glycol thiol (PEG-SH, MW = 2000, Aldrich), oleyl amine (OLAm, 80-90%, Acros Organics), 
chloroform (CLF, Fisher), tetrahydrofuran (THF, Fisher), isopropanol (iPrOH, Fisher) were 
used as received. 
Synthesis of copper complexes. 
All the syntheses were carried out under ambient conditions. The synthesis of copper sulfide 
NPs in aqueous environment and from CuSCN are reported in the Supporting Information. 
Among the synthesized complexes, Cu(dedtc)2 is very soluble in a variety of organic solvents 
(chloroform, dichloromethane, acetone), Cu(xan) is only sparingly soluble in chloroform, while 




Cu(dedtc)2. To 20 mL of a 0.2 M aqueous solution of Na(dedtc), 5 mL of a 0.4 M aqueous 
solution CuCl2·2H2O were added dropwise. A dark brown appeared immediately. The mixture 
was left under stirring for 20 min. The precipitate was collected, washed three times with water 
and dried overnight under vacuum at room temperature. The dark brown complex was stored 
in a desiccator. Elemental analysis. Calcd.: C 33.4%, H 5.6%, N 7.8%, S 35.6%. Exp.: C 
33.0(2)%, H 5.6(1)%, N 7.6(1)%, S 33.5(2)%. 
Cu(xan). To 10 mL of a 0.2 M aqueous solution of K(xan), 5 mL of a 0.4 M aqueous solution 
CuCl2·2H2O were added dropwise. A yellow precipitate formed immediately and became 
slightly darker in color over the course of 30 min. The precipitate was collected, washed three 
times with water and dried overnight under vacuum at room temperature in the dark. The bright 
yellow complex was stored in a desiccator and wrapped in aluminum foil to avoid possible UV-
prompted decomposition. Calcd.: C 19.5%, H 2.7%, S 34.7%. Exp.: C 19.4(1)%, H 2.8(1)%, S 
33.3(2)%. 
Cu(tba)2. K(tba) was prepared adding 5 mL of Htba (64.2 mmol) to 100 mL of a stirring 
solution of 4.4 g (32.1 mmol) of K2CO3 in 100 mL of water. The yellow solution was stirred 
for 2 h and the water was then removed with the aid of a rotary evaporator. The beige precipitate 
was collected, re-dissolved in 50 mL of water, filtered and dried again. K(tba) was collected as 
a beige powder and used without further purification. For the synthesis of the copper complex, 
to 10 mL of a 0.4 M aqueous solution of K(tba), 5 mL of a 0.4 M aqueous solution CuCl2·2H2O 
were added dropwise. A yellow precipitate formed immediately, which turned orange upon 
stirring over the course of 2 h. The precipitate was collected, washed three times with water and 
dried overnight under vacuum at room temperature in the dark. The bright orange complex was 
stored in a desiccator and wrapped in aluminum foil to avoid possible UV-prompted 
decomposition. Calcd.: C 49.8%, H 3.0%, S 19.0%. Exp.: C 47.9(1)%, H 3.1(1)%, S 17.7(1)%. 




The synthesis of copper sulfide NPs from the thermolysis of the prepared copper complexes 
were carried out in the same way. 30 mg of the chosen complex were introduced in a 50-mL 
three-neck round-bottom flask along with 10 mL of OLAm. The solution was degassed at 90 °C 
for 30 min and then the flask was then purged with N2. The temperature was set to 220 °C and 
aliquots were sampled at different temperatures as well as at different time marks after reaching 
the set temperature. All the aliquots were quenched in toluene and the NPs precipitated adding 
acetone. The particles were collected through centrifugation (30,000 rcf, 10 min) and finally re-
dispersed in toluene for optical characterization. For TEM observations, the particles were 
diluted in chloroform. 
To synthesize the CuS NPs used in the study, the same procedure outlined above was followed 
but, upon reaching 200 °C, the reaction mixture was rapidly quenched to room temperature. 
Three mL of toluene were added to the crude reaction product, followed by the addition of 
30 mL of acetone and centrifugation at 3,820 rcf for 10 min. The particles were then re-
dispersed in toluene and precipitated with acetone 3 more times. The particles were stored in 5 
mL of toluene at 5 °C. 
Transfer of CuS NPs to water. 
The hydrophobic CuS NPs were transferred to water and made biocompatible upon exchanging 
the OLAm molecules on the surface for PEG-SH. In a typical procedure, 500 μL of the CuS 
NPs toluene suspension were precipitated with acetone, recovered upon centrifugation and re-
dispersed in 250 μL of THF. 10 mg of PEG-SH were added to the suspension, followed by 1 
mL of water. The mixture was sonicated for 30 s and vortexed for 1 min. Finally, it was stirred 
at 70 °C to evaporate the THF. Upon cooling, the exchanged OLAm crushed out of solution. 
The suspension in water was centrifuged at 30,000 rcf for 5 min and the solid discarded. The 
aqueous suspension of CuS NPs was diluted to 2 mL with water (or the desired buffer) and 
filtered through a 0.45 μm syringe filter. This procedure yielded an optically clear suspension 




stability of the suspension, few milligrams of PEG-SH were added, followed by addition of 
excess iPrOH, centrifuged at 30,000 rcf at 4 °C for 45 min and re-dispersed in the desired 
aqueous medium. 
Physicochemical characterization. 
The NPs were imaged on carbon-coated copper grids using a JEM1400 Flas (JEOL) microscope 
operating at 100 kV acceleration voltage. The size of the nanoparticles was estimated from the 
TEM images, counting at least 200 NPs using ImageJ software. The hydrodynamic size was 
obtained at 25°C, using a Malvern Zetasizer Nano ZS90 (Malvern) with a detection angle of 
173° and an equilibration time of 120 s. The optical extinction spectra were recorded at room 
temperature with an UV/VIS/NIR spectrophotometer (Perkin Elmer Lambda1050) using a 4-
nm step. Infrared spectra were obtained in transmission mode on a Spectrum Two instrument 
(Perkin Elmer) in the 450-4000 cm-1 range with 4 cm-1 resolution, preparing KBr tablets 
containing 1%wt of the analyzed material. Elemental analysis of the metal complexes was 
carried out on a CHNS-932 (LECO) elemental analyzer using 1 mg of sample, using the Dumas 
method, which is based on a direct oxidative combustion of the sample at 1000 °C. The 
composition of copper sulfide NPs synthesized in the presence of acetylacetone was assessed 
using a total X-ray fluorescence (TXRF) instrument S2 PICOFOX (Bruker). 
Heat conversion efficiency determination. 
The light-to-heat transduction capability of the CuS NPs was evaluated according to a method 
reported in the literature. The set-up is sketched in the Supporting Information (Figure S6). Two 
wells of a 24-well plate were filled with 500 μL of de-ionized water and an aqueous dispersion 
of CuS NPs. Both liquids will be referred to as sample in this context. The sample was irradiated 
with a 1280-nm fiber-coupled laser and the temperature was registered using a E40bx infrared 
thermal camera (FLIR), controlled through the built-in software. The heating-cooling curves 
were directly derived from the live images recorded using the thermal camera and the total 




The acquisition of the heating-cooling curves was performed three times for water and CuS 
NPs respectively. 
Cytotoxicity tests. 
The HeLa human cervical epithelial cell line was grown in Dulbecco's Modified Eagle's 
Medium (DMEM, Gibco, Paisley, Scot- land, UK) supplemented with fetal calf serum (FCS 
10%, Gibco) and 0.5% of antibiotics (penicillin G [10,000 U/mL] and streptomycin sulfate 
[10,000 mg/mL] (Gibco)). Cells were grown in a Thermo Scientific Midi 40 CO2 Incubator 
(Thermo Fisher Scientific Inc.) with a 5% CO2 atmosphere, a 95% relative humidity and a 
constant temperature of 37 ºC. 
The viability of HeLa cells exposed to CuS NPs was analyzed by the MTT assay[36]. Twenty-
four hours after appropriate treatments with CuS NPs, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) solution was added to each well at a concentration of 0.5 
ng/mL, and plates were incubated at 37 ºC for 2 h. The resulting formazan crystals were 
dissolved by the addition of DMSO and absorbance was measured at 540 nm. Cell viability was 
estimated as a percentage relative to the mean absorption obtained from control cells (not 
incubated with the CuS NPs; 100% viability). 
OCT measurements. 
OCT measurements were conducted using two different instruments: one working in spectral-
domain (SD) and one in time-domain (TD). The former is a Thorlabs Telesto OG-1300 with a 
maximum working wavelength of 1300 nm (range 1250-1380 nm), mounting a LSM03 scan 
lens with a working distance of 25.1 mm, having an axial scan rate of up to 92 kHz and axial 
resolution in water of 4.9 μm, with a maximum imaging depth of 2.5 mm. The latter is a 
commercially available OPTIS™ OCT Imaging System for intravascular imaging equipped 
with a Dragonfly™ OPTIS™ Imaging Catheter (St Jude Medical/Abbott) used in clinical 




resolution in tissue of 15 μm, with a maximum imaging depth of 3 mm. For both experiments, 
store-bought pork fat was used as model tissue where the contrast agents were injected. 
Statistical Analysis. 
The quantitative data and sample size of cell viability results were expressed as mean ± standard 
deviation (SD) and numbers (n), respectively. Excel® from the Microsoft® suite was the 
software used for statistical analysis. 
 
Supporting Information 
Supporting Information is available from the Wiley Online Library or from the author. 
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Figure 1. A) TEM images of CuS NPs synthesized at 200 °C from Cu(tba)2, capped with 
OLAm (dispersed in chloroform) and PEG-SH (dispersed in water). Scale bars are 100 nm. B) 
Geometrical diameter and thickness of the plate-like CuS NPs as obtained from TEM images. 
C) Results of DLS measurements performed on a phosphate buffer (1x PB) dispersion of 
PEG-SH-capped CuS NPs. D) X-ray diffraction (XRD) pattern of the CuS NPs compared to 





Figure 2. A) Extinction spectra of CuS NPs in toluene (dark green) and in water (light green), 
respectively before and after exchanging surface OLAm molecules for PEG-SH. Dashed 
segments in the spectrum of the aqueous dispersion were manually drawn in correspondence of 
strong water absorption regions. B) Simulated extinction cross section (ext) of CuS NPs in 
water, along with the ratio of absorption (abs) over the total extinction (ext) that includes both 
absorption and scattering (scat) components. C) Heating-cooling curves obtained from 
irradiation of water (light blue) and CuS NPs aqueous dispersion (light green) with 1280 nm 
laser. Black lines in the cooling parts of the curves are single exponential fits to the data. D) 
Absorption efficiency at 1280 nm (as experimentally calculated) versus NP largest feature of 
plasmonic NPs investigated as OCT contrast agents (GNSt – gold nanostar). The data shown in 





Figure 3. Viability percentage of HeLa cells incubated for 4 and 24 h with dispersions of CuS 
NPs at different concentrations. Each point corresponds to the mean value (along with its 





Figure 4. OCT B-scans of Eppendorf tubes containing (from top to bottom): dispersion of CuS 





Figure 5. Results of the OCT tests conducted using a SD-OCT instrument (A-D) and an OCT 
instrument for intravascular imaging (E-G). A) Sketch of the approach employed to test the 
dark contrast abilities of CuS NPs in pork fat, along with a visualization of the mechanism 
giving rise to dark contrast. B) Picture of the specimen of the imaged pork fat post injection of 
CuS NPs and GNSs suspensions. C and D) OCT B-scans obtained in correspondence of the 
areas where the two types of contrast agents were respectively injected, along with the OCT 
signal intensity derived from the signal integration on the ROIs indicated in the scans. E) 
Breakdown of the setup employed for the OCT test using a catheter. The red light observed in 
the catheter is an idle signal used to indicate where the 1320 nm probing light and the rotating 
mirror are located. The two rectangles labelled 1 (pristine tissue) and 2 (injected CuS NPs) in 
the middle picture indicate respectively the areas where the OCT images shown in G were 
recorded. F) Sketch of section indicated in the bottom picture in E, showing how dark contrast 
is generated. G) OCT images obtained from the two areas highlighted in E. All scale bars (in 





Figure 6. TEM images (A), extinction spectra (B), geometrical and hydrodynamic size (C), and 
X-ray diffraction patterns (D) of the copper sulfide NPs synthesized in the quest for OCT dark 
contrast agents. Scale bars in A are 100 and 20 nm for the two top and the two bottom TEM 
images. In C, the geometrical size reported is the largest NP’s feature (i.e., for plate-like 
particles, the thickness is not reported). The reference patterns in D are taken from PDF # 01-
078-2121 (covellite), # 00-036-0379 (yarrowite), # 00-023-0958 (roxbyite). In E, some of the 






Copper sulfide nanoparticles with localized plasmonic resonance in the second optical 
transparency window were synthesized from thermolysis of copper complexes. The prominent 
absorption character of their extinction cross section, along with small size and lack of 
apparent cytotoxicity made them ideal candidates to unprecedently achieve dark contrast in 
optical coherence tomography. 
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Synthesis of copper sulfide nanoparticles in water. In a typical synthesis of copper sulfide 
nanoparticles in aqueous environment, 1 mL of a 0.1 M aqueous solution of Na2S·9H2O was 
swiftly injected into 50 mL of an aqueous solution of the selected ligand and Cu2+ (see details 
in Table S1). After 5 min of stirring at room temperature, the 100-mL round-bottomed flask 
was transferred to an oil bath pre-heated at 90 °C and the mixture was kept under stirring at that 
temperature for a total of 1h. During this time, aliquots were sampled, quenched to room 
temperature and their absorption spectra were recorded (Figure S1). The aliquots selected for 
further transmission electorn microscopy (TEM) observations were precipitated with 
isopropanol (iPrOH), recovered by means of centrifugation (30,000 rcf for 20 min at 4 °C), and 
washed once with a mixture of water and iPrOH. The particles were finally stored in de-ionized 
water (dH2O). 
 
Table S1. Summary of the experimental conditions (nature and quantity of ligands) used for 
the synthesis of copper sulfide nanoparticles in water. The pH adjustment was performed using 
a 0.2 M NaOH solution. 
 





citrate Na(cit)·2H2O 17.6 [0.06] 17.0 [0.1] - 
EDTA H4EDTA 29.2 [0.1] 17.0 [0.1] pH adjusted to 9 
GSH L-gluthathione 30.7 [0.1] 17.0 [0.1] pH adjusted to 9 
MHDA Mercaptohexadecanoic acid 22.6 [0.08] 17.0 [0.1] pH adjusted to 8 
MPA Mercaptopropionic acid 21.9 [0.2] 17.0 [0.1] pH adjusted to 9 





Synthesis of copper sulfide nanoparticles from CuSCN. The synthesis of these particles was 
carried out according to a slightly modified, previously reported method.1 Briefly, 60 mg of 
CuSCN was added to 10 mL of oleylamine (OLAm) in a 50-mL three-neck round-bottom flask 
and stirred under vacuum at 100 °C for 30 min. Afterwards, the reaction environment was 
purged with N2 and the temperature was risen to 240 °C. Upon reaching the target temperature, 
the reaction was allowed to proceed for 1 h. Afterwards, the flask was quenched in cold water, 
the crude product transferred to centrifuge tubes and precipitated upon addition of excess 
acetone and the particles were collected by means of centrifugation (3,820 rcf for 10 min). The 
particles were re-collected and washed three times with a mixture of toluene and acetone. The 
particles were finally stored in chloroform. The transfer of these nanoparticles to water via 
ligand replacement (PEG-SH for OLAm molecules) was performed using the same procedure 





Figure S1. Summary of the properties of the copper sulfide nanoparticles synthesized directly 
in water. Absorption spectra of aliquots sampled at different time-marks (A), along with the 
temporal evolution of the localized surface plasmon resonance (LSPR) band maximum (B). 





Figure S2. Absorption spectra (A) and TEM images (B) of the copper sulfide nanoparticles 
synthesized via thermolysis of Cu(xan), Cu(tba)2 and Cu(dedtc)2. Absorption spectra were 
acquired from aliquots sampled at different time-points, quenched in toluene, precipitated with 






Figure S3. Fourier-transform infrared (FTIR) spectra of the copper complexes used for the 
preparation of copper sulfide nanoparticles, along with the ones of the corresponding ligands. 
With colored shaded areas signature signals present in the ligand and in the copper complex are 
indicated. In Cu(tba)2, some differences can be observed between the signals of the complex 
and the ligand. The signals in these regions arise mainly from the carboxylic O-H bend (850-
950 cm-1), aromatic C-C stretch (1450-1600 cm-1) and the carbonyl group stretch (1650-1700 
cm-1). These differences are possibly indicative of some residual moisture in Cu(tba)2, which is 
also supported the appearance of weak signals just below 3500 cm-1, a difference coordination 
of the metal to the ligand (either via the oxygen or the sulfur atom) and a different stacking of 
the aromatic moieties. The solution of the crystal structure of this complex lies beyond the scope 
of the proposed study, hence no further investigation was carried out. 
 
 
Figure S4. TEM image of copper sulfide nanoparticles obtained upon stirring Cu(tba)2 in 





Modelling of CuS NPs’ electronic properties 
The theoretical results presented in the main text and in Figure S5 were obtained with COMSOL 
Multiphysics, a commercial FEM package used to solve arbitrary systems of differential 
equations. With it, we calculate the full-wave electrodynamic response of a single isolated CuS 
nanoplate, immersed in a homogeneous dielectric environment, under continuous wave 
linearly-polarized illumination. The platelet was modeled attending to the dimensions obtained 
in the experimental characterization of the sample, and its edges were rounded (with a radius 
of 0.5 nm) to avoid pathological results arising from unphysically sharp edges.  
In order to connect these results with that of a randomly oriented ensemble of nanoplates, 
relevant for the colloidal suspension studied in the manuscript, we presented in Figure 2B the 
results averaged over six different combinations of light’s incidence and polarization relative 
to the plate. It is worth noting that the plate supports two main plasmonic modes, one with the 




Figure S5. Absorption cross sections for a resonance excited with the electric field polarized 
along the long side (longitudinal) and along the short side (transversal) of the plate. The inset 
shows the geometry of the plate and its dimensions in the model. The rounding radius of the 






The permittivity of the CuS plate was modeled using the Drude model: 
where 𝜀∞ is the permittivity at high frequencies, 𝜔𝑝 is the plasma frequency of the material, 𝛾 
is the damping rate and 𝜔 is the angular frequency of the impinging light. The values of these 
parameters are listed in Table S2. Importantly, the value of the plasma frequency for CuS is 
estimated from the expected population of carriers supporting the plasmonic charge oscillation, 
which in this case are the holes in the degenerate semiconductor, as 𝜔𝑝 = √
𝑒2𝑁h
𝑚h𝜀0
, where e is 
the elemental charge, Nh is the hole density, mh is the reduced mass of the holes and 𝜀0 is the 
permittivity of free space. Now, the dielectric constant of the background environment has been 
estimated for simplicity as the simple average of the dielectric index of the solvent (𝜀𝐻2𝑂 =
1.332) with that of the capping agent (𝜀𝑃𝐸𝐺 = 1.4552). 
 
Table S2. Parameters describing CuS permittivity, with frequencies expressed in units of 
energy.2  
𝜺∞ 𝑵𝒉, cm-3 𝒎𝒉 𝝎𝒑, eV 𝜸, eV 
9 1022 0.8 𝑚0 4.15 0.4 








Calculation of the heat conversion efficiency of CuS NPs 
The heat conversion efficiency was calculated as reported in the main text (Equation 1), using 
the experimentally obtained parameters reported in Table S3. 
The heat inputs at the numerator were calculated by measuring the temperature T achieved by 
the system at the thermal equilibrium, through the expression: 
where Troom is room temperature, while hA is the product between the heat transfer coefficient 
and the area of the sample in contact with the environment, calculated as 
where m and cp are the mass and heat capacity of water and CuS NPs suspension, and τ is the 
sample time constant, obtained by fitting the cooling part of the heating curves. 
The error associated with the final heat conversion efficiency was calculated using standard 
error propagation, considering the error associated with cooling rate (i) and temperature 
increase (Ti) of water and CuS NPs suspension, and the impinging laser power (I) reading. 
The OD was obtained recording the absorption spectrum of the same suspension used for the 
heat conversion efficiency calculation in a 4-mm optical path cuvette and considering an optical 
path of approx. 2.62 mm in the case of 0.5 mL of CuS NPs suspension in a 15.6-mm diameter 
cylindrical well.  
 
Table S3. Summary of the parameters used for the calculation of the heat conversion efficiency. 
Were applicable, errors on the last digit are given in parentheses. 
 m, g cp, Jg-1K-1 T, K , s I, mW OD 
CuS NPs 0.5 4.186 10.22(3) 175.0(2) 152(1) 0.252 
water 0.5 4.186 5.76(4) 202.2(4) 152(1)  
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